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sequence of which corresponded to human PDGF-D (GenbankPlatelet-derived growth factor-D expression in developing and
number AF336376).mature human kidneys.
Conclusions. To our knowledge, these are the first studiesBackground. Platelet-derived growth factor (PDGF) is a fam-
to localize PDGF-D in human kidneys and suggest that PDGF-Dily of growth regulatory molecules composed of sulfide-bonded
may have a role in kidney development. PDGF-D was showndimeric structures. Two well-studied PDGF peptides (PDGF-A
and PDGF-B) have been shown to mediate a wide range of to bind to PDGF  receptor, which localizes to mesangial cells,
biological effects. PDGF-D is a newly recognized member of parietal epithelial cells, and interstitial fibroblasts, suggesting
the PDGF family. Initial studies of the PDGF-D gene found potential paracrine interactions between those cells and the
its expression in cells of the vascular wall, suggesting that it could visceral epithelium.
participate in vascular development and pathology. However,
its localization in human kidney tissues has never been studied.
Methods. PDGF-D expression in fetal (N  30) and adult
Platelet-derived growth factor (PDGF) is a family of(N 25) human kidney tissues was examined by immunohisto-
growth regulatory molecules composed of sulfide-bondedchemistry using an affinity-purified antibody raised to human
PDGF-D. Antibody absorption with the immunizing peptide was dimeric structures. It was originally discovered as a factor
employed to confirm the specificity of this antibody. PDGF-D promoting the proliferation of fibroblasts and smooth
protein and gene expression in human kidneys also were dem- muscle cells [1, 2]. Until recently, two PDGF peptides,onstrated by Western blotting and reverse transcription-poly-
PDGF-A and PDGF-B, which are able to form three di-merase chain reaction (RT-PCR).
Results. In the developing kidney, PDGF-D was first ex- meric isoforms as PDGF-AA, PDGF-AB, and PDGF-BB,
pressed by epithelial cells of comma- and S-shaped structures have been thought to comprise all of the members of the
of the developing nephron, and most consistently in the visceral PDGF signaling system [3, 4]. These PDGF ligands exert
epithelial cells in the later stages of glomerular differentiation.
their action on responsive cells by binding to the cellIn addition, PDGF-D could be found in mesenchymal, pre-
membrane tyrosine kinase receptors consisting of - andsumptively fibroblast cells in the interstitium of developing renal
pelvis and in fetal smooth muscle cells in arterial vessels. In the -isoforms that dimerize upon ligand binding to form the
adult normal kidney, PDGF-D was expressed by the visceral PDGFR-, -, or - isoforms [5–12]. The biological
epithelial cells. There was persistent expression in arterial smooth activity of PDGF-A and PDGF-B chains and PDGF muscle cells as well as in some neointimal smooth muscle cells
and  receptors have been extensively studied in bothof arteriosclerotic vessels, and expression in smooth muscle
experimental models and human settings [13–26].cells of vasa rectae in the medulla. PDGF-D could be identified
at the basolateral membrane of some injured tubules in areas As a result of analysis of the Biotechnology Informa-
of chronic tubulointerstitial injury routinely encountered in tion EST databases, two additional isoforms of PDGF
aging kidneys. Western blotting of homogenates of adult kid-
termed PDGF-C and PDGF-D have been recently iden-neys demonstrated monospecific bands at 50 kD corresponding
tified [27–29]. Human PDGF-D encodes a protein of 370to previously established size parameter for this protein. RT-
PCR of human kidney RNA resulted in a 918 basepair band, the amino acids and has three domain structures: an amino-
terminal CUB domain, a C-terminal PDGF/vascular endo-
thelial growth factor (VEGF)-homology domain (growth
Key words: growth regulatory molecule, platelet-derived growth factor,
factor domain or core domain), and an intermediarydeveloping nephron, vascular development, protein PDGF-D, fibro-
blasts, glomerulogenesis arteriosclerosis. bridge region with no homology to other protein do-
mains. There is also a single putative site for N-linked
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core domain and the full-length structure, respectively antibody is non-reactive with either full-length or growth
factor domain of PDGF-C, or with PDGF-A and PDGF-B[38]. In addition, PDGF-D has approximately 25% over-
all amino acid identity with PDGF-A and PDGF-B [28]. chains.
PDGFRb. Rabbit polyclonal antibody (lot no. PR7649;A PDGF-D expression profile in different human organs
including kidneys was reported by using real-time quan- provided by Dr. D.F. Bowen-Pope) recognizes PDGFR
by Western blotting and stains mesangial cells by immu-titative polymerase chain reaction (PCR) and Northern
blot analysis [27, 28]. It also has been demonstrated that nohistochemistry as previously described [14]. It detects
patterns of PDGFR similar to those detected by anti-PDGF-D is able to bind with PDGF receptor  [27, 28].
PDGF-D could be expressed in human fibroblasts and body PR7212 as previously used and referenced by our
group [16], but has the advantage of working well incells of the vascular wall and could stimulate the prolifer-
ation of human smooth muscle cells, suggesting that it methacarn fixed tissues.
Muscle-specific actin. Murine monoclonal antibodymight play a role in vascular development and disease
[29]. PDGF-D protein expression in mouse embryos us- (clone 1A4; Dako Corp., Carpinteria, CA, USA) has been
well characterized by Western blotting [30]. It has beening immunohistochemistry demonstrated its staining in
developing heart, lung, kidneys and some muscle deriva- previously demonstrated to recognize alpha-smooth mus-
cle actin in methyl Carnoy’s fixed tissues [16], and wastives [27].
Although PDGF-D has been reported to be expressed used as a marker of mesangial cells as previously de-
scribed [31].in human kidney, its precise expression in specific cell
types is controversial. Uutela et al could not find PDGF-D WT-1. Rabbit polyclonal antibody (cat no. sc-192, lot
no. D301; Santa Cruz Biotechnology Inc., Santa Cruz,mRNA expression in a human kidney cell line [29]. To
address this issue, our current study was designed to CA, USA) was raised against a peptide of the carboxy
terminus of Wilms’ tumor (WT) protein of human origin.demonstrate PDGF-D expression in specific cell types
by performing immunohistochemistry in developing and It has been characterized by tissue immunohistochemis-
try and Western blotting [32–35], and was used as amature human kidneys. We also utilized Western blot-
ting and reverse transcription (RT)-PCR in order to es- phenotypic marker of visceral epithelial cells (podocytes)
as previously described [35, 36].tablish the existence of this molecule in human kidneys
at protein and RNA levels. Ulex europaeus agglutinin I. A lectin glycoprotein (lot
no. 91129; Vector Laboratories, Burlingame, CA, USA)
established to be a marker of endothelial cells by lectin
METHODS
binding was used to identify glomerular and vascular
Tissue selection endothelial cells as previously described [37, 38].
Human fetal kidneys (N  30) with estimated gesta-
Immunohistochemistrytional ages ranging from 54 to 122 days were obtained
fresh from tissue examined after therapeutic abortions. Immunohistochemistry was performed on four-micron
sections of methyl Carnoy’s fixed, paraffin-embeddedThese studies have received human subjects approval by
an institutional IRB review panel (UW 96-1826-A-08). tissues following a standard avidin-biotin complex (ABC)
method. Briefly, sections were deparaffinized in xyleneTissues were fixed in methyl Carnoy’s (methacarn) solu-
tion (60% methanol, 30% chloroform, 10% acetic acid) and rehydrated with graded ethanols. Endogenous per-
oxidase was blocked with 3% hydrogen peroxide and theand processed and embedded in paraffin according to
conventional techniques. samples were then rinsed in phosphate-buffered saline
(PBS). For reduction of background labeling, the sec-Normal-appearing human adult kidney tissues (N 
25) were obtained fresh from uninvolved portions of tions were blocked by using the avidin-biotin blocking
kit (Vector Labs) per the manufacturer’s instruction andkidneys surgically resected for localized renal cell carci-
noma, or from cadaver donor kidneys unable to be uti- Normal Goat Serum (Kirkegaard & Perry Laboratories,
Gaithersberg, MD, USA) for 30 minutes. The sectionslized for transplantation, under an IRB approved proto-
col (M-1183). Tissues were fixed in methacarn solution were incubated overnight at 4C with rabbit anti-human
PDGF-D polyclonal antibody diluted 1:100 in PBS con-and processed as stated earlier.
taining 1% bovine serum albumin (BSA) and 5% non-
Antibodies fat dry milk. After washing in PBS, the sections were
sequentially incubated with biotinylated goat anti-rabbitPDGF-D–chain. Rabbit polyclonal antibody (lot no.
E0259, provided by ZymoGenetics Inc., Seattle, WA, IgG (Vector Labs) and the ABC-Elite reagent (Vector
Labs) Finally, 3,3-diaminobenzidine (DAB; with nickelUSA) is an affinity-purified antibody raised against the
middle part of PDGF-D molecule. It recognizes the full- chloride enhancement) was used as the chromogen and
sections were counterstained with methyl green, dehy-length human PDGF-D peptide but does not recognize
the isolated growth factor domain (GFD) peptide. This drated and cover slipped.
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For all samples, a negative antibody control consisted (SDS) and -mercaptoethanol was added, and then the
protein sample was boiled and the pellet discarded.of substitution of the primary antibody with normal rab-
The protein samples were loaded on to 8 to 16% poly-bit IgG. Transfected BHK-570 cells (expressing PDGF-C)
acrylamide gels, electrophoretically size-separated, andor transfected Chinese hamster ovary (CHO) cells (ex-
then transferred to nitrocellulose membranes. The mem-pressing PDGF-D) as well as their parenteral BHK and
branes were rinsed with Tris-buffered saline (TBS; pHCHO cells (kindly provided by ZymoGenetics) were
7.6) and were blocked with 5% non-fat dry milk in TBSused as positive and negative controls to establish the
containing 1% BSA at 37C for two hours. The mem-sensitivity and specificity of the antibody to PDGF-D
branes were then incubated overnight with a 1/1500 dilu-for immunohistochemical procedures.
tion of rabbit polyclonal anti-PDGF-D antibody at 4C.
Double labeling immunohistochemistry After thoroughly washing in TBS with 0.3% Tween-20,
the membranes were sequentially incubated with goatFour-micron sections of methyl Carnoy’s-fixed, paraf-
anti-rabbit IgG alkaline phosphatase conjugated for 30fin embedded tissues were prepared for immunohisto-
minutes, washed, developed with a chemiluminescentchemistry as described above. The slides were incubated
substrate (CSPD; Applied Biosystems, Foster City, CA,with murine monoclonal antibody against-smooth mus-
USA) and exposed to film. The full-length PDGF-Dcle actin, rabbit polyclonal anti-PDGFR antibody, rab-
protein (kindly provided by ZymoGenetics) was usedbit polyclonal WT-1 antibody, or Ulex europaeus aggluti-
as the positive protein control. As a negative antibodynin I. These were followed by biotinylated anti-mouse
control, the primary antibody was replaced by normalIgG, biotinylated goat anti-rabbit IgG, or biotinylated
rabbit IgG at an equivalent concentration. The full-Ulex, and then the ABC-Elite reagent, and DAB to give
length and growth factor domain PDGF-C protein alsoa brown reaction. Peroxidase activity was blocked again
were used to confirm the non-reactive of anti-PDGF-Dwith 3% hydrogen peroxide. Then, the sections were
antibody to PDGF-C. In addition (not shown) this anti-sequentially incubated with Normal Goat Serum to re-
body does not cross-react with PDGF-A or PDGF-Bduce the background labeling, rabbit polyclonal anti-
protein.human PDGF-D antibody with an overnight incubation,
biotinylated goat anti-rabbit IgG, the ABC-alkaline phos- RT-PCR
phatase reagent (Vector Labs), and finally a blue sub-
To demonstrate PDGF-D gene expression in kidneystrate kit (Vector Blue Alkaline Phosphatase Substrate
tissues, total cellular RNA from normal and transplantKit III; Vector Labs) to yield a blue reaction product.
nephrectomies was extracted with RNAqueous-Midi kit
The slides were counterstained with Nuclear Fast Red (RNAqueous-Midi; Ambion Inc., Austin, TX, USA)
(Vector Labs), dehydrated and cover slipped. and stored at70C until use. Approximately two micro-
grams of RNA was mixed with the RT mixture per in-Antibody absorption
structions in the OneStep RT-PCR kit (Qiagen Inc., Chats-
The immunizing PDGF-D peptide used to generate worth, CA, USA) and then reverse-transcribed with
anti-PDGF-D antibody was resuspended in PBS, incu- PDGF-D primers (Life Technologies, Grand Island, NY,
bated with rabbit polyclonal anti-PDGF-D antibody at USA) for 30 minutes at 50C. The sequences of the
4C overnight (the excess concentration of the peptide PDGF-D primers were 5-GTGCAGAGTCCTAGA
to antibody was 100:1), and then used as the absorbed TTCCC-3 for the forward primer and 5-GAGGTGGT
primary antibody in a standard ABC immunohistochem- CTTGAGCTGCAG-3 for the reverse primer. After the
istry procedure in kidney sections and BHK-570 cell lines hot start at 95C for 15 minutes, 32 cycles of amplification
expressing the full-length PDGF-D protein. Concurrent were carried out with the following processes: denatur-
controls included repeating the procedure in an identical ation at 94C for one minute, annealing at 59C for one
fashion but without the PDGF-D peptide absorption minute, extension at 72C for one minute in each cycle
step. and 10 minutes at the last cycle. RT-PCR products were
resolved on a 1% agarose gel containing ethidium bro-
Protein preparation and Western blotting mide and were visualized under ultraviolet illumination.
Approximately 250 milligrams of frozen adult kidney RNA was replaced by nuclease free water as the negative
were minced and washed thoroughly in PBS. After cen- control for RT-PCR assays. The RT-PCR product was
trifugation and removing the tissue debris, the suspen- cloned and sequenced to confirm its identity with PDGF-D.
sion buffer [0.1 mol/L NaCl, 0.01 mol/L Tris-HCl pH 7.6,
0.001 mol/L ethylenediaminetetraacetic acid (EDTA) pH
RESULTS8.0, 1 g/mL aprotinin, and 100 g/mL phenylmethylsul-
Immunohistochemistryfonyl fluoride (PMSF)] was added and the tissue was
dispersed in Tissuemizer. For Western reducing condi- Human fetal kidney. Expression of PDGF-D was not
identified in the metanephric blastema or the vesicletions, 2 sample buffer with sodium dodecyl sulfate
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Fig. 1. Immunolocalization of PDGF-D in
developing human kidney. (A) In a low power
view of a fetal kidney of estimated 83 days of
gestational age, PDGF-D is demonstrated in
various stages of glomerulogenesis, but not
in the metanephric blastema (arrows) or the
vesicle developing as the earliest stage of glom-
erulogenesis. (B) PDGF-D is weakly expressed
by epithelial cells (arrowheads) in the comma-
and S-shaped structures. (C ) PDGF-D is ex-
pressed by visceral epithelial cells and some
parietal epithelial cells of the glomerulus at
early stages of differentiation. (D) PDGF-D
expression confined to visceral epithelial cells
of the maturing glomerulus. (E, F ) In extra-
glomerular structures, PDGF-D is expressed
by fibroblast-like mesenchymal cells within
the renal pelvis (E), and by medial smooth
muscle cells of muscular arteries (F).
stage of early nephron formation (Fig. 1A). In the later of them had foci of nonspecific chronic changes including
global glomerulosclerosis, tubular atrophy, interstitial fi-stages of development, PDGF-D was weakly expressed
by the epithelial cells of comma- and S-shaped structures brosis and arteriosclerosis most likely related to aging [39].
In adult normal kidneys, PDGF-D was uniformly ex-(Fig. 1B) and strongly expressed by the visceral epithelial
cells of more differentiated glomeruli (Fig. 1 C, D). pressed by visceral epithelial cells but not by other glo-
merular structures (Fig. 2 A, B). There was widespreadPDGF-D was expressed by some parietal epithelial cells
in differentiated glomeruli (Fig. 1C). Extraglomerular expression of this protein in the medial smooth muscle
cells of arteries and arterioles that was similar to thestructures of developing kidney showing the expression
of this protein included the basement membrane of im- expression pattern identified in developing kidney (Fig.
2C), as well as in smooth muscle cells of vasa rectae inmature collecting ducts, fibroblast-like mesenchymal
cells in the interstitial area of the renal pelvis (Fig. 1E), the medullary area (Fig. 2D). PDGF-D expression was
not detected in normal tubular and interstitial cells.and medial smooth muscle cells of arteries (Fig. 1F).
Human adult kidney. Most kidney specimens had nor- There were focal changes in PDGF-D expression in areas
of chronic renal damage, where it was identified in scle-mal histology by conventional light microscopy. Some
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Fig. 2. Immunolocalization of PDGF-D in
mature human kidney. (A, B show higher
power view) PDGF-D is expressed by visceral
epithelial cell of the glomerulus. (C ) PDGF-D
is expressed by medial smooth muscle cells of
arteries, similar to that shown in Fig. 1F. (D)
PDGF-D expression is present in the medul-
lary area (arrows). PDGF-D staining struc-
tures in these areas are vasa rectae (inset).
(E ) PDGF-D is expressed at the basolateral
membrane of some injured tubules (arrows),
but not by normal tubules (arrowheads). (F )
There is expression of PDGF-D by some neo-
intimal cells (arrow) in arteriosclerotic vessels.
Table 1. Double labeling immunohistochemical staining pattern in developmental kidney
Metanephric Metanephric Differentiated Mature Ureteric
blastema vesicle Comma-S-stage glomerulus glomerulus bud
PDGF-D () () (	) faintly in EP (	) VEP and PEP (	) PEP ()
PDGFR (	) () () (	) mesangium (	) mesangium ()
-smooth muscle actin ()a ()b ()c (	) mesangium (	) mesangium ()
WT-1 () (	) focal (	) EP (	) nucleus of VEP (	) nucleus of VEP ()
Ulex europaeus ()a () (	) EC (	) EC (	) EC ()
Abbrevations are: EP, epithelial cells; VEP, visceral epithelial cells; PEP, parietal epithelial cells; EC, endothelial cells; WT-1, Wilm’s tumor. Symbols are: (), nega-
tive; (	), positive.
a Components of vasculature in blastema and interstitium demonstrate the expression
b Perivascular mesenchymal cells are positive staining for alpha-smooth muscle actin
c Mesenchymal cells within the glomerular clefts demonstrate positive staining for alpha-smooth muscle actin
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Fig. 3. Double immunolabeling of PDGF-D with antibody markers of different cell types in developing human kidney. (A) Alpha-smooth muscle
actin (brown) is localized to mesangial cells, while PDGF-D (blue) is localized to visceral epithelial cells of the glomerulus. (B) PDGFR (brown)
is expressed by mesangial cells, while PDGF-D (blue) is expressed by visceral epithelial cells of the glomerulus. (C ) Co-localization of WT-1
(brown, nuclear stain), a phenotypic marker of visceral epithelial cells, and PDGF-D (blue, cytoplasmic stain) in the same cells in the differentiated
glomerulus confirms that PDGF-D is expressed by visceral epithelial cells. PDGF-D also is expressed by some parietal epithelial cells. (D) Ulex
europaeus agglutinin I (brown) stains endothelial cells, while PDGF-D (blue) is consistently expressed by visceral epithelial cells of the maturing
glomeruli. (E ) Ulex europaeus agglutinin I (brown) stains endothelial cells of muscular arteries, while PDGF-D (blue) stains medial smooth
muscle cells. (F ) Serial tissue section of that shown in E, demonstrating co-localization of alpha-smooth muscle actin (brown) and PDGF-D (blue)
in the same cells confirms that PDGF-D positive cells are arterial smooth muscle cells. (Publication of this figure in color was made possible by
a grant from ZymoGenetics, Seattle, Washington.)
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Table 2. Double labeling immunohistochemical staining pattern in mature kidney
Glomerular Glomerular Interstitial
capillary EC mesangium VEP PEP Tubule Vessel cells
PDGF-D () () (	) () ()a (	)b SMC ()
PDGFR () (	) () (	) () (	) vascular adventitial cells (	)
-smooth muscle actin () (	) () () () (	) SMC (	)
WT-1 () () (	) () () () ()
Ulex europaeus agglutinin I (	) () () () ()c (	) EC ()
Abbrevations are: EC, endothelial cells; VEP, visceral epithelial cells; PEP, parietal epithelial cells; SMC, smooth muscle cells. Symbols are: (), negative; (	),
positive.
a The staining is positive at the cellular basement membrane of the damaged tubules
b The staining also is positive in neointimal cells of arteriosclerotic vessels and vasa rectae in the medullary area
c The staining is positive in peritubular capillary endothelial cells
rotic glomeruli, in basolateral membranes of injured tu- (Fig. 5 A-D). The immunostaining of the basement mem-
bules (Fig. 2E), and in some neointimal cells of arterio- brane of immature collecting ducts and that of fibroblast-
sclerotic vessels (Fig. 2F). like mesenchymal cells in the renal pelvis of developing
kidney could be abolished also by the same procedure
Double labeling immunohistochemistry (Fig. 5 E and F). These findings helped establish the
The localization of PDGF-D expression in developing specificity of the antibody for the immunohistochemical
and normal adult kidneys was confirmed by double-label- procedures reported.
ing immunohistochemical techniques using additional The presence of PDGF-D protein in human kidney
antibodies to identify phenotypic markers of different was confirmed by Western blot analysis of tissue-extracted
cell types. Ulex europaeus agglutinin I was used to iden- protein from normal and transplant kidneys using the
tify endothelial cells. Expression of WT-1 identified vis- polyclonal anti-PDGF-D antibody. The 50 kD monospe-
ceral epithelial cells. While no specific markers of mesan- cific bands corresponding to the size of the PDGF-D
gial cells in tissue sections have been identified, PDGFR monomer as indicated by using a control preparation of
is expressed in the mesangium of differentiated glomer- PDGF-D full-length protein were identified in the kidney
uli [16] and -smooth muscle actin, a marker for smooth tissue extract running under reducing condition (Fig.
muscle cells, has been identified in mesangial cells of 6). The anti-PDGF-D antibody recognized PDGF-D full-
differentiated glomeruli [16]. Furthermore, PDGFR length protein at approximately 90 kD running under non-
and alpha-smooth muscle actin have been shown to be reducing condition (data not shown).These results were
expressed also in the activated mesangial cells in disease consistent with the biochemical properties of PDGF-D
states of both experimental and human models [13, 14, in other reports (90 kD unreduced and 49 to 55 kD re-
31, 40]. Therefore, PDGFR and -smooth muscle actin duced) [27, 28]. The specificity of this antibody also was
were used as markers of mesangial cells in this study. confirmed by immunoblotting, which demonstrated that
In developing kidney, the results of double immuno- neither PDGF-C growth factor domain nor full-length
staining for PDGFR, -smooth muscle actin, WT-1, protein reacted with anti-PDGF-D antibody.
Ulex europaeus agglutinin I, and PDGF-D are summa-
RT-PCRrized in Table 1 and shown in Figure 3. In mature normal
kidney, the results of double immunostaining for these Platelet-derived growth factor-D mRNA expression
antibodies are summarized in Table 2 and shown in Fig- in the kidney was analyzed by RT-PCR. A PDGF-D
ure 4. The double immunolabeling studies confirmed nucleotide fragment of the expected length (918 bp)
that PDGF-D was expressed by visceral epithelial cells could be detected in kidney tissue extracts obtained from
of glomeruli in developing and mature kidneys. In addi- normal and transplant nephrectomies by using RT-PCR
tion, the co-expression of -smooth muscle actin and primers specific for PDGF-D (Fig. 7). The specificity of
PDGF-D by neointimal cells of arteriosclerotic vessels RT-PCR product was confirmed by DNA sequencing.
indicates that PDGF-D expressing cells in this site are The DNA sequence was matched with human PDGF-D
likely to be smooth muscle cells. nucleotides 365-1283 of Genbank number AF336376
(data not shown).
Antibody specificity and Western blotting
Preincubation of anti-PDGF-D antibody with the im-
DISCUSSIONmunizing peptide completely abolished the specific im-
This study demonstrates PDGF-D protein and genemunostaining of glomerular epithelial cells, and arterial
smooth muscle cells of developing and mature kidneys expression in human kidneys by Western blotting and
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Fig. 4. Double immunolabeling of PDGF-D with antibody markers of different cell types in mature human kidney. (A) Alpha-smooth muscle
actin (brown) is expressed by mesangial cells and PDGF-D (blue) is expressed by visceral epithelial cells in the glomerulus. Alpha-smooth muscle
actin also stains extraglomerular interstitial fibroblasts. (B) PDGFR (brown) stains mesangial cells, while PDGF-D (blue) stains visceral epithelial
cells in the glomerulus. (C ) Ulex europaeus agglutinin I (brown) binds endothelial cells, while PDGF-D (blue) stains visceral epithelial cells in
the glomerulus. (D) Co-localization of PDGF-D (blue) with WT-1 (brown) in the glomerulus confirms that PDGF-D is expressed by visceral
epithelial cells. (E, F ) In arteriosclerotic vessels, PDGF-D (blue) is co-localized with alpha-smooth muscle actin (brown, in E) in medial smooth
muscle cells and neointimal cells and is distinct from the double immunolabeling pattern with ulex europaeus agglutinin I (brown, in F) which
binds endothelial cells. (Publication of this figure in color was made possible by a grant from ZymoGenetics, Seattle, Washington.)
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Fig. 5. Immunostaining of mature (A–D) and developing (E, F ) human kidneys with anti-PDGF-D antibody and with absorbed antiserum. Tissue
sections reacted with anti-PDGF-D antibody (A, C, and E). Adjacent sections to that shown in A, C, and E reacted with absorbed antiserum (B,
D, and F). There is complete abolition of PDGF-D staining, confirming the specificity of this antibody.
RT-PCR in agreement with previous studies by others PDGF-D was localized to epithelial cells transitioning
from the early developing nephrons of the comma- and[27, 28]. We extend the information available on PDGF-D
by localizing its expression in developing and mature S-shaped stages to the visceral epithelial cells of differen-
tiated glomeruli, concurrent with PDGF receptor local-human kidneys using immunohistochemical techniques.
Platelet-derived growth factor-D was not detectable ization to the mesangial cells of differentiated glomeruli.
In the developing pelvis, PDGF-D was expressed at thein the earliest stages of glomerulogenesis, and it was not
detected in the metanephric blastema or surrounding basement membrane of immature collecting ducts and
by presumptive fibroblastic cells in the interstitium.cortical interstitial cells. In contrast, PDGF  receptor
was expressed by the primitive mesenchymal cells of There are several growth factor-receptor interactions
that are essential for epithelial-mesenchymal interac-the metanephric blastema and surrounding primordial
interstitial cells. In later stages of glomerulogenesis, tions in metanephric development. As recently reviewed
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Fig. 6. Western blot analysis utilizing anti-PDGF-D antibody reacts
with the reduced form of PDGF-D full-length protein (lane 1) but
does not react with PDGF-C growth factor domain protein (lane 2) or
PDGF-C full-length protein (lane 3). The antibody does react with
normal kidney (lane 4) and transplant nephrectomy (lane 5). The immu-
noreactive protein in the 50 kD region corresponding to the PDGF-D Fig. 7. Reverse transcriptase-polymerase chain reaction analysis de-
full-length protein is identified in normal and transplant nephrectomies. tected PDGF-D mRNA expression in human kidneys. The DNA
The band in the 36 kD region corresponds to the N-terminally cleaved marker used was a 500-bp ladder (lane 1). A band corresponding to
portion. No immunoreactive band is found in PDGF-C growth factor the expected length of PDGF-D PCR product (918 bp) is identified in
domain and full-length protein, confirming the specificity of antibody. normal and transplant nephrectomies (lanes 2 and 3, respectively). No
Normal rabbit Ig G reacted with homogenates of normal kidney and expression is identified in the negative control sample (lane 4).
transplant nephrectomy as a negative antibody control are demon-
strated in lanes 6 and 7.
and parietal cells within the glomerulus, and by intersti-by Kanwar et al [41] and Bard [42], growth factors that
tial cells of fibroblast/myofibroblast type. PDGF-D mayhave direct effects on individual compartments of kidney
serve a local paracrine trophic function for glomerulardevelopment include FGF-7, GDNF, VEGF, angiopoie-
cells bearing the PDGF  receptor. This might be similartin, and PDGF-B. FGF-7 knockout mice have small kid-
to a role that has been hypothesized for vascular endo-neys, while GDNF-deficient mice demonstrate kidney
thelial growth factor (VEGF), another growth factor con-agenesis. VEGF and angiopoietin have been directly
stitutively expressed by visceral epithelial cells, with re-linked to the formation of the glomerular capillary net-
spect to the maintenance of fenestrations of glomerularwork. PDGF-B and PDGF  receptor have been shown
capillary endothelial cells, which express a receptor pro-to be key regulatory molecules for mesangial develop-
tein for VEGF [43–47]. Alternatively, secreted PDGF-Dment in the glomerulus, since mice in which PDGF-B
conceivably could exert an effect on cells present in distalor PDGF  receptor have been genetically deleted fail
portions of the nephron and in the lower urinary tract,to develop mesangial cells [20, 21]. As PDGF-D is an
or perhaps systemically. Since so little is currently knownadditional ligand for PDGF  receptor and is expressed
about the regulation of PDGF-D release from variousat early stages of glomerulogenesis, we speculated that
cell types, we are unable to offer a more specific schemaPDGF-D may have roles in kidney development in a
for a functional role for constitutively expressed PDGF-D.paracrine/juxtacrine manner, as PDGF-D might be se-
Its ability to engage the PDGF  receptor strongly sug-creted into the developing glomerulus and interact with
gests a role for PDGF-D in promoting proliferation andthe PDGF  receptor in regulating mesangial cell precur-
migration of mesangial and interstitial cells in the kidney,sors or contributing to subsequent mesangial cell devel-
based on numerous studies of injury accompanied byopment.
engagement of PDGF  receptor by its other principalIn the fully differentiated glomeruli of fetal kidneys,
ligand, PDGF-B chain [6, 9, 16, 20–22].and in glomeruli of mature human kidneys, there is per-
In renal arteries of developing and mature kidneys,sistent and uniform PDGF-D expression by visceral epi-
PDGF-D is expressed by medial smooth muscle cells. Itthelial cells, again confirmed by double immunostaining.
is additionally expressed by some neointimal cells ofPDGF-D can be a phenotypic marker of visceral epithe-
arteriosclerotic vessels. PDGF-D positive cells in the vas-lial cells in both developing and mature kidneys and may
cular intima are likely to be smooth muscle cells as demon-be useful for studying the role of visceral epithelial cells
strated by double immunolabeling of these neointimalin kidney diseases. The significance of widespread ex-
cells expressing PDGF-D with the phenotypic markerpression of PDGF-D by visceral epithelial cells is un-
-smooth muscle actin. A previous study by Uutela et alknown. The principal receptor for PDGF-D, the PDGF
receptor, is constitutively expressed by mesangial cells demonstrated that PDGF-D stimulated proliferation and
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larity to the B-type PDGF receptor. Proc Natl Acad Sci USAsurvival of cultured serum-starved human coronary ar-
86:4917–4921, 1989
tery smooth muscle cells [29]. Taken together with our 12. Heldin CH, Ernlund A, Rorsman C, Ronnstrand L: Dimeriza-
tion of B-type platelet-derived growth factor receptors occurs afterobservations, these studies suggest that PDGF-D may
ligand binding and is closely associated with receptor kinase activa-have proliferative and chemotactic activity for smooth
tion. J Biol Chem 264:8905–8912, 1989
muscle cells that contributes to the development of vas- 13. Fellstrom B, Klareskog L, Heldin CH, et al: Platelet-derived
growth factor receptors in the kidney-upregulated expression incular sclerosis, and that such PDGF-D activity is at least
inflammation. Kidney Int 36:1099–1102, 1989in part derived from neointimal cells present in such
14. Iida H, Seifert R, Alpers CE, et al: Platelet-derived growth factor
lesions where it may have local autocrine and paracrine (PDGF) and PDGF receptor are induced in mesangial proliferative
nephritis in the rat. Proc Natl Acad Sci USA 88:6560–6564, 1991effects.
15. Gesualdo L, Pinzani M, Floriano JJ, et al: Platelet-derivedIn summary, we describe the localization of PDGF-D,
growth factor expression in mesangial proliferative glomerulo-
a recently identified member of the PDGF family, in nephritis. Lab Invest 65:160–167, 1991
16. Alpers CE, Seifert RA, Hudkins KL, et al: Developmental pat-developing and mature kidneys. It is likely that this mole-
terns of PDGF-receptor, and alpha-actin expression in humancule has significant effects on renal development and on
glomerulogenesis. Kidney Int 42:390–399, 1992
the renal response to injury in view of its ability to engage 17. Abboud HE: Growth factors in glomerulonephritis. Kidney Int
43:252–267, 1993the PDGF  receptor and its expression in arterioscle-
18. Isaka Y, Fujiwara Y, Ueda N, et al: Glomerulosclerosis induced byrotic vessels. in vivo transfection of transforming growth factor-beta or platelet-
derived growth factor gene into the rat kidney. J Clin Invest
92:2597–2601, 1993ACKNOWLEDGMENTS
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